In the 1980s, when pharmaceutical companies were looking to cut costs and speed up the process of getting drugs through the cumbersome federal review and approval process, an industry was born: contract research organizations, or CROs.
These private companies, staffed with scientists and analysts, are designed to provide pharmaceutical companies and federal health agencies with everything from testing new drugs to evaluating the safety and ethics of industry clinical trials - once the domain of in-house staff and university campuses.
And they're becoming increasingly popular because of the emphasis they place on fast results.
Universities "are not all about efficiency and speed, you know, it's a whole different mode," said Don Holzworth, Constella Group founder and chief executive officer. "It's pure thought leadership - they are paid to sit back and think and think and think and think, and then publish."
http://www.fortwayne.com/mld/belleville/news/nation/17161471.htm
Subscribe to:
Post Comments (Atom)
1 comments:
That's amazing because the company keeps telling employees at their international unit that they are totally committed to improving policies in poor, developing countries using USAID funds. Meanwhile, Constella actively seeks multiple strategies with Big Pharma and the USG to to push the drugs of the day.
Post a Comment